Dr. Fishbane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Old Country Rd
Ste 135
Mineola, NY 11501Phone+1 516-663-2170Fax+1 516-663-4619
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Nephrology, 1991 - 1993- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1989 - 1991
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1988 - 1989
Albert Einstein College of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 1990 - 2025- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- A Study Of Oral Paricalcitol To Treat Proteinuric Renal Disease Start of enrollment: 2006 Jul 01
- Healthy Transitions in Late Stage Kidney Disease Start of enrollment: 2013 Oct 01
- Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis Start of enrollment: 2014 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- 89 citationsA Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.Steven Fishbane, Martin Ford, Masafumi Fukagawa, Kieran McCafferty, Anjay Rastogi
Journal of the American Society of Nephrology. 2019-06-14 - 83 citationsClinical Management of Hyperkalemia.Biff F. Palmer, Juan Jesus Carrero, Deborah J. Clegg, Gates B. Colbert, Michael Emmett
Mayo Clinic Proceedings. 2021-03-01 - 266 citationsA nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.G L Semenza, G L Wang
Molecular and Cellular Biology. 1992-12-01
Journal Articles
- Administrative Leadership: Nephrologists in Non-Nephrology Leadership RolesMichael Gitman, Alessandro Bellucci, Steven Fishbane, Advances in Chronic Kidney Disease
Lectures
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/10/2019
- Intravenous Epoetin Alfa-Epbx Versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney DiseaseAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
Authored Content
- A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with PruritusJanuary 2020
Press Mentions
Northwell Announces $1.25M Endowed, First-of-Its-Kind Kidney FellowshipJuly 20th, 2022- Common Gene Variant May Predict Peritoneal Dialysis OutcomesOctober 20th, 2021
- FibroGen to Present Safety and Efficacy Analyses from Roxadustat Global Phase 3 Program at American Society of Hematology Annual MeetingDecember 2nd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
